Beyond diagnostic applications, several antitumor therapies are known from the literature that act through the direct inhibition of the APN/CD13 molecule, and also various NGR-conjugated therapeutic brokers have been developed that deliver different cytotoxins (e
Beyond diagnostic applications, several antitumor therapies are known from the literature that act through the direct inhibition of the APN/CD13…